↓ Skip to main content

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib

Overview of attention for article published in BMC Cancer, September 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
79 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
Published in
BMC Cancer, September 2019
DOI 10.1186/s12885-019-6121-3
Pubmed ID
Authors

R. de Haan, E. van Werkhoven, M.M. van den Heuvel, H. M. U. Peulen, G. S. Sonke, P. Elkhuizen, M. W. M. van den Brekel, M. E. T. Tesselaar, C. Vens, J. H. M. Schellens, B. van Triest, M. Verheij

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 79 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 10%
Researcher 7 9%
Student > Ph. D. Student 7 9%
Student > Master 6 8%
Librarian 6 8%
Other 14 18%
Unknown 31 39%
Readers by discipline Count As %
Medicine and Dentistry 26 33%
Unspecified 6 8%
Biochemistry, Genetics and Molecular Biology 6 8%
Agricultural and Biological Sciences 3 4%
Nursing and Health Professions 1 1%
Other 6 8%
Unknown 31 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2021.
All research outputs
#18,691,046
of 23,163,378 outputs
Outputs from BMC Cancer
#5,482
of 8,403 outputs
Outputs of similar age
#254,427
of 340,817 outputs
Outputs of similar age from BMC Cancer
#88
of 161 outputs
Altmetric has tracked 23,163,378 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,403 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,817 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 161 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.